ArticleHaematologica2014

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

Matthew J J Rose-Zerilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.